Mange (various types)

Mange is a highly contagious parasitic skin disease affecting virtually all species of farm animals, caused by microscopic mites that infest the skin and cause intense irritation, hair loss, and skin damage. Several distinct types of mange occur in livestock, each caused by different mite species with varying host preferences, anatomical locations, and clinical presentations. The condition has plagued domestic animals for thousands of years and remains a significant cause of economic loss and welfare concern in modern livestock production systems worldwide. Understanding the specific type of mange affecting an animal or herd is essential for selecting appropriate treatment and implementing effective control measures.

Mange affects cattle, sheep, goats, pigs, llamas, alpacas, and poultry, with certain mite species showing strong host specificity while others can infest multiple species. Sarcoptic mange, caused by Sarcoptes scabiei variants, affects multiple livestock species and is perhaps the most clinically severe form due to the burrowing behavior of these mites within the skin. Psoroptic mange, particularly sheep scab caused by Psoroptes ovis, is highly contagious among sheep and causes devastating outbreaks in affected flocks. Chorioptic mange, caused by Chorioptes species, commonly affects the lower legs of cattle and horses and is usually less severe than sarcoptic or psoroptic forms. Demodectic mange, caused by Demodex mites that live in hair follicles, occurs in cattle and goats and may be associated with immunosuppression.

The economic and welfare impact of mange on livestock operations can be substantial, particularly when infestations are allowed to become severe before treatment. Affected animals suffer significant discomfort from intense pruritus, leading to self-trauma, reduced feed intake, and impaired production. Weight loss and poor growth rates in affected animals translate directly to economic losses for producers. Hide and fleece damage reduces the value of these products and may render them commercially worthless in severe cases. Labor and treatment costs add to the financial burden, and certain forms of mange such as sheep scab may trigger regulatory actions including movement restrictions. The welfare implications of untreated mange, including chronic suffering from persistent itching and skin damage, make prompt recognition and treatment an ethical imperative.

Mange is highly treatable with modern antiparasitic medications, though successful control requires accurate diagnosis of the specific mite species involved and appropriate treatment selection. Early detection improves treatment outcomes and reduces spread within herds or flocks. Several forms of mange, particularly sheep scab in some countries, are notifiable diseases requiring reporting to veterinary authorities and potentially triggering mandatory control measures. Prevention through biosecurity measures, quarantine protocols, and strategic treatment programs can effectively protect livestock populations from mange introduction and establishment. Working with a veterinarian to develop appropriate prevention and treatment strategies is essential for managing this common and economically important condition.

Mange in livestock is caused by various species of microscopic mites belonging to several genera, each with distinct biological characteristics and clinical presentations. Sarcoptic mange, the most severe form, is caused by host-adapted variants of Sarcoptes scabiei, a burrowing mite that tunnels into the superficial layers of the skin to lay eggs. Female Sarcoptes mites create serpentine burrows in the stratum corneum where they deposit eggs and fecal material that triggers intense allergic reactions. Sarcoptic mange occurs in cattle, sheep, goats, pigs, and camelids, with each host species typically harboring species-specific or subspecies-specific mite variants. This form of mange is zoonotic, meaning it can temporarily infest humans who have close contact with affected animals.

Psoroptic mange is caused by non-burrowing mites of the genus Psoroptes that live on the skin surface and feed on lymph and tissue fluids. Psoroptes ovis causes sheep scab, one of the most economically important ectoparasite diseases of sheep worldwide, capable of spreading rapidly through flocks and causing severe welfare compromise. Psoroptes cuniculi affects the ears of goats and sheep, causing otoacariasis with intense head shaking and ear scratching. In cattle, Psoroptes bovis causes body mange while Psoroptes natalensis affects the ears. Unlike Sarcoptes, Psoroptes mites complete their entire life cycle on the host animal over approximately two to three weeks, making infestations highly persistent without treatment.

Chorioptic mange, caused by Chorioptes bovis and related species, typically affects the lower legs, tail head, and udder areas of cattle and may spread to other species including sheep and goats. These surface-dwelling mites cause less intense clinical signs than sarcoptic or psoroptic mites in most cases, though severe infestations can cause significant skin damage and discomfort. Demodectic mange, caused by Demodex species that inhabit hair follicles, occurs as either localized or generalized forms. Demodex bovis in cattle and Demodex caprae in goats typically cause nodular lesions containing colonies of mites within dilated hair follicles. Generalized demodicosis often indicates underlying immunosuppression and may require investigation of concurrent disease.

Transmission of mange mites between animals occurs primarily through direct physical contact, making mange highly contagious within groups of livestock. Mites can also spread via contaminated equipment, bedding, housing facilities, and handling chutes that have contacted infested animals. Environmental survival varies by mite species and conditions, with Sarcoptes and Psoroptes capable of surviving off the host for several days to weeks under favorable cool, humid conditions. Overcrowding, poor nutrition, concurrent disease, and other stressors increase both the risk of transmission and the severity of clinical disease in affected animals. Young animals and those with compromised immune function are particularly susceptible to severe infestations.

The pathophysiology of mange involves both direct tissue damage from mite feeding and burrowing activities and immunological responses to mite antigens and waste products. Burrowing mites like Sarcoptes cause mechanical disruption of the epidermis and trigger inflammatory responses that result in the characteristic thickening and crusting of affected skin. Mite saliva, feces, and body components act as allergens, stimulating both immediate hypersensitivity reactions causing pruritus and delayed hypersensitivity contributing to chronic skin changes. The intense itching leads to self-trauma through scratching, rubbing, and biting at affected areas, causing additional skin damage and creating opportunities for secondary bacterial infection. In chronic infestations, the skin undergoes progressive changes including hyperkeratosis, acanthosis, and fibrosis that can persist even after successful mite elimination.

Early warning signs of mange often include behavioral changes reflecting the onset of pruritus before obvious skin lesions develop. Affected animals begin scratching, rubbing against fences and structures, or biting at their skin more frequently than normal herdmates. Restlessness and apparent discomfort, particularly at rest, may be observed as animals repeatedly shift position or interrupt normal activities to scratch. Initial skin changes may be subtle, including small areas of hair loss, mild scaling, or slight thickening of the skin that can easily be overlooked during routine observation. Close examination may reveal the presence of mites on skin scrapings even when clinical signs are minimal, emphasizing the value of early investigation of any unusual scratching behavior.

Symptom presentation varies considerably between livestock species and the specific type of mange involved. Sarcoptic mange in cattle typically begins on the head, neck, and withers before potentially spreading across the entire body in severe cases. Affected cattle develop intense pruritus, thickened and wrinkled skin, crust formation, and progressive hair loss. In pigs, sarcoptic mange commonly affects the ears, face, and eventually the entire body, with heavily affected animals developing the characteristic rough, thickened skin that significantly impacts carcass value. Sheep with sarcoptic mange show wool loss, crusty lesions, and rubbing behavior, though this form is less common than psoroptic mange in many regions. Goats with sarcoptic mange display similar signs, often beginning around the ears, face, and lower legs.

Behavioral changes in animals with established mange infestations reflect both the constant irritation and the systemic effects of chronic infestation. Affected animals spend excessive time scratching and rubbing rather than grazing or resting, leading to reduced feed intake and poor utilization of consumed feed. Sleep and rest patterns become disrupted as animals awaken to scratch, contributing to stress and poor condition. Social behavior may change, with some animals becoming isolated while others cluster together, potentially facilitating transmission within groups. In severe cases, animals may develop areas of self-inflicted trauma including excoriation, bleeding wounds, and secondary infections from persistent scratching and rubbing.

Physical signs of mange progress through characteristic stages as infestations become established and spread. Early lesions include papules, erythema, and small areas of scaling that may go unnoticed without careful examination. As infestations progress, hair or wool loss becomes increasingly apparent, with affected areas developing thickened, folded, or corrugated skin. Crust formation from dried serum and inflammatory exudate creates the characteristic scabby appearance that gives rise to the common names for various mange forms. Chronic infestations lead to extensive hyperkeratosis, creating thick, plaque-like areas of abnormal skin that may crack and fissure. Secondary bacterial infection of damaged skin can cause additional inflammation, pustule formation, and systemic illness.

Symptom progression in untreated mange follows a predictable pattern of increasing severity and spread. Localized infestations gradually expand as mite populations increase and spread to adjacent skin areas. Without treatment, lesions eventually may cover large portions of the body, causing severe hide or fleece damage and significant animal suffering. Production impacts become increasingly apparent as infestations progress, with weight loss, reduced milk production, and impaired reproductive performance reflecting the metabolic costs of chronic parasitism and constant irritation. Emaciation and debilitation can develop in severe, prolonged cases, and death may occasionally occur in very young or immunocompromised animals with overwhelming infestations.

Emergency symptoms requiring immediate veterinary intervention include severe generalized infestation with extensive skin damage, particularly in young or debilitated animals at risk of systemic complications. Signs of secondary bacterial infection including fever, depression, swelling, and purulent discharge indicate need for antibiotic therapy alongside antiparasitic treatment. Severe self-trauma with open wounds or evidence of blood loss requires urgent attention to prevent further deterioration. Animals showing signs of severe stress, debilitation, or inability to maintain normal activities due to mange infestation need immediate treatment to address both the parasitic cause and supportive care needs. Suspected sheep scab or other reportable forms of mange require prompt veterinary involvement for diagnosis and regulatory compliance.

Clinical examination provides strong presumptive evidence of mange based on characteristic signs including pruritus, hair loss, and skin changes typical of mite infestation. Veterinarians assess the distribution and character of lesions, noting whether patterns suggest sarcoptic, psoroptic, chorioptic, or demodectic mange. The presence and intensity of itching behavior, response to scratching during examination, and the animal's overall condition help gauge infestation severity. Examination should include all animals in the affected group to assess the extent of herd or flock involvement and identify subclinically affected individuals. History of recent animal introductions, known mange in contact animals, and previous treatment attempts provides important context for diagnosis.

Laboratory confirmation of mange relies primarily on identification of mites or their eggs in skin scrapings from affected areas. Superficial scrapings using a scalpel blade moistened with mineral oil collect material from the skin surface where Psoroptes and Chorioptes mites reside. Deep skin scrapings that produce capillary bleeding are necessary for detecting Sarcoptes mites in their epidermal burrows. Multiple scraping sites increase diagnostic sensitivity, as mites may be present in low numbers or unevenly distributed across lesions. Material collected is examined microscopically for presence of mites, eggs, or fecal pellets. For suspected demodectic mange, material should be obtained from within nodular lesions by squeezing to express follicular contents.

Differential diagnosis of mange includes various other conditions that cause pruritus, alopecia, and skin changes in livestock. Lice infestations, caused by both biting and sucking lice, produce similar clinical signs and often occur concurrently with mange. Ringworm causes circular areas of alopecia and scaling but typically causes less pruritus than mange. Photosensitization affects non-pigmented skin areas exposed to sunlight, creating a distinct distribution pattern. Allergic dermatitis from insect bites, feeds, or environmental allergens can cause intense pruritus but usually lacks the progressive crusting characteristic of mange. Zinc deficiency and other nutritional causes of skin disease should be considered, particularly in animals with additional signs of malnutrition. Bacterial or fungal skin infections may complicate mange or occur independently.

Herd-level diagnostics are particularly important for managing mange outbreaks and implementing effective control programs. Examination of multiple animals helps determine the prevalence and severity of infestation within the group. Identification of the specific mite species involved guides treatment selection and regulatory compliance, as different mange types have different reporting requirements and treatment protocols. Monitoring treatment response through follow-up examinations and skin scrapings confirms successful mite elimination. For reportable conditions such as sheep scab, official veterinary involvement may be required for diagnosis, and laboratory confirmation may be necessary before declaring an outbreak or certifying disease freedom.

Emergency and immediate treatment priorities for severe mange focus on relieving animal suffering while initiating effective mite control. Animals with severe infestations causing significant distress should receive prompt antiparasitic treatment rather than waiting for diagnostic confirmation. Separating severely affected animals from less affected herdmates prevents continued transmission and allows more intensive individual care. Initial assessment determines whether supportive treatments such as anti-inflammatory medications, antibiotics for secondary infections, or nutritional support are needed alongside antiparasitic therapy. For animals in very poor condition, humane considerations may indicate that euthanasia is more appropriate than attempting treatment.

Systemic antiparasitic treatment forms the foundation of mange therapy in modern livestock practice, with macrocyclic lactone compounds being the primary treatment class. Ivermectin, administered by injection, provides effective treatment for sarcoptic, psoroptic, and chorioptic mange in cattle, sheep, goats, and pigs when given at appropriate doses and intervals. Two treatments at seven to fourteen day intervals are typically recommended to kill mites that emerge from eggs after the initial treatment. Doramectin and moxidectin offer longer duration of action that may improve efficacy with single-dose protocols in some situations. Milbemycin compounds provide alternative options in some species. Withdrawal times for meat and milk vary by product and species and must be strictly observed in food-producing animals. Some injectable products are prohibited in lactating animals producing milk for human consumption.

Topical treatments provide alternative or complementary approaches to mange control, particularly useful when injection is impractical or systemic treatment is contraindicated. Pour-on formulations of macrocyclic lactones offer convenient application for cattle and some other species, though efficacy may be reduced compared to injectable routes for certain mite species. Amitraz dips or sprays are effective against various mange mites and may be used alone or in combination with systemic treatments. Lime sulfur applications provide a traditional treatment option effective against multiple mite species. For localized lesions, particularly in demodectic mange, topical application of miticidal preparations directly to affected areas may be sufficient. Complete and thorough coverage of affected areas is essential for topical treatments to succeed.

Supportive care measures improve treatment outcomes and animal welfare during mange recovery. Secondary bacterial infections of damaged skin require antibiotic treatment based on likely pathogens and severity of infection. Anti-inflammatory medications may be appropriate for severely affected animals to reduce discomfort during the treatment period. Nutritional support through high-quality feed and appropriate supplementation helps animals recover body condition lost during infestation. Environmental treatments to reduce mite contamination of housing, equipment, and bedding complement animal treatments and reduce re-infestation risk. Isolation of treated animals from untreated or newly introduced animals prevents re-exposure during the treatment period.

Whole-herd or whole-flock treatment protocols are essential for effective mange control when multiple animals are affected or at risk. Treating all animals in the group simultaneously prevents re-infestation of treated individuals by mites from untreated herdmates. Strategic timing of treatments, such as during housing periods when animals are in close contact, can improve control program efficacy. For reportable conditions like sheep scab, regulatory authorities may mandate specific treatment protocols and movement restrictions. Follow-up examinations and skin scrapings several weeks after treatment completion confirm successful mite elimination and identify any animals requiring retreatment.

Treatment decisions must consider both animal welfare and economic factors, particularly for severely affected animals with questionable recovery prognosis. The costs of intensive treatment, potential production losses during recovery, and the risk of treatment failure in severe cases must be weighed against the animal's value and the impact of culling. For valuable breeding animals, aggressive treatment is usually warranted even for severe infestations. For commercial animals nearing market weight, early marketing of mildly affected animals or humane euthanasia of severely affected individuals may be more appropriate than prolonged treatment. These decisions should be made in consultation with the herd veterinarian, considering both economic factors and animal welfare obligations.

Recovery from mange following successful treatment typically occurs over several weeks as damaged skin heals and hair or fleece regrows. Clinical improvement including reduced pruritus and resolution of active inflammation usually becomes apparent within one to two weeks after effective treatment. Skin lesions gradually improve, with crusts loosening and eventually falling away to reveal healing epidermis beneath. Hair regrowth in previously affected areas may take four to eight weeks or longer depending on the severity and duration of infestation. Complete restoration of normal skin and coat may require several months in animals with extensive chronic lesions that caused significant structural damage to skin and hair follicles.

Post-treatment care and monitoring ensure successful recovery and detect any treatment failures requiring additional intervention. Animals should be examined regularly during the recovery period to confirm continued improvement and absence of recurrent signs. Follow-up skin scrapings at three to four weeks post-treatment provide objective confirmation of mite elimination and identify cases requiring retreatment. Body condition should be monitored and nutritional support continued until animals regain normal weight and production levels. Housing and equipment used by treated animals should be cleaned and treated to eliminate environmental mite contamination that could cause re-infestation.

Prognosis for animals with mange is generally good when appropriate treatment is provided before severe damage occurs. Mild to moderate infestations typically resolve completely with proper treatment, and affected animals return to normal health and production. Severe chronic infestations may result in permanent skin damage including scarring, abnormal skin texture, and patchy hair regrowth that affects appearance and potentially hide value. Animals that have experienced severe debilitation during infestation may require extended recovery periods to fully regain body condition and production capacity. Rarely, secondary complications such as chronic skin infections or systemic illness may complicate recovery even after successful mite elimination.

Return to production considerations depend on the species, production purpose, and severity of infestation experienced. Withdrawal times for antiparasitic treatments must be completed before animals can be marketed for meat or their milk used for human consumption. Breeding animals should demonstrate complete recovery before returning to reproductive service, as the stress of pregnancy, lactation, or breeding activity could trigger recurrence in incompletely recovered animals. Show and exhibition animals may require extended recovery periods for complete coat restoration before competition. Proper documentation of treatments, withdrawal periods, and disease freedom status supports marketing and compliance with buyer requirements.

Biosecurity measures form the foundation of mange prevention programs, focusing on preventing introduction of mites to uninfested herds or flocks. All newly acquired animals should be carefully examined for signs of mange before entering the main herd and ideally quarantined and treated prophylactically regardless of clinical status. Prophylactic treatment with systemic antiparasitic medications during quarantine eliminates mites that may be present at subclinical levels. Quarantine periods of three to four weeks allow observation for clinical signs that might develop from incubating infestations. Source verification and health certification help ensure that purchased animals come from mange-free premises and reduce introduction risk.

Strategic treatment programs can effectively prevent mange establishment and maintain herd or flock freedom from these parasites. Regular prophylactic treatment during high-risk periods, such as housing in winter when animals are in close contact, can prevent population buildup and clinical disease. Treatment of all animals before introducing them to groups containing susceptible individuals prevents spread from subclinically infested carriers. Coordination with veterinarians to develop appropriate treatment schedules based on local mange risks, production calendar, and available products optimizes prevention program effectiveness. Documentation of treatments supports health certification and regulatory compliance.

Environmental management reduces mite survival and transmission opportunities within livestock facilities. Regular cleaning of housing facilities, handling equipment, and transport vehicles removes mite contamination from surfaces. Treatment of buildings and equipment with appropriate acaricides may be indicated following outbreaks or before introducing animals to previously contaminated facilities. Reducing stocking density decreases contact transmission opportunities and the stress that increases susceptibility to clinical disease. Providing adequate nutrition and managing other health issues maintains animal immunity and resistance to mange infestation.

Management practices that reduce animal stress and maintain overall health contribute significantly to mange prevention. Well-nourished animals with robust immune function are more resistant to clinical mange even when exposed to mites. Routine health programs addressing other parasites, infectious diseases, and nutritional deficiencies help maintain the overall health status that provides natural resistance to mange. Avoiding mixing of animals from different sources reduces transmission opportunities and exposure to potentially new mite strains. Prompt isolation and treatment of any animals showing signs of skin disease prevents spread to healthy herdmates.

Quarantine and testing protocols for mange focus on preventing introduction through purchased animals and detecting infestations early. New arrivals should be housed separately from the main herd for at least three weeks while being observed for any signs of skin disease. Examination by a veterinarian including skin scrapings provides additional assurance of mange freedom before release to the main group. Prophylactic treatment during quarantine provides additional protection even when no clinical signs are present. Records of animal sources, quarantine procedures, and treatments support trace-back investigations if mange subsequently appears and demonstrate due diligence in prevention efforts.

Daily management and monitoring for mange should be integrated into routine livestock care practices, with particular attention during high-risk periods. Stockpersons should observe animals daily for excessive scratching, rubbing, or other signs of skin irritation that might indicate mange infestation. Regular handling and close examination during routine procedures such as weighing, vaccination, or reproductive management provide opportunities to detect early skin changes before infestations become severe. Establishing baseline knowledge of normal coat condition and behavior for each group enables recognition of subtle changes that warrant investigation. Training all personnel in recognition of mange signs ensures consistent surveillance across the operation.

Housing and environmental management significantly influence mange risk and should be optimized for prevention. Housing facilities should provide adequate space per animal to minimize close contact that facilitates mite transmission. Regular cleaning and maintenance of housing structures, fencing, and equipment reduces environmental mite contamination. Proper ventilation in enclosed housing reduces humidity that favors mite survival and helps maintain coat and skin health. Bedding should be clean, dry, and changed regularly, with contaminated bedding from suspected mange cases disposed of or composted to kill mites. Treatment of facilities with acaricides may be warranted following outbreaks or before reintroducing animals to previously affected housing.

Herd health programs should incorporate mange surveillance and prevention alongside other health management activities. Regular veterinary involvement provides expertise for early disease recognition, appropriate treatment selection, and program evaluation. Integration of mange prevention with broader parasite control programs ensures comprehensive protection while avoiding unnecessary treatments. Seasonal timing of prevention activities based on local risk patterns and production calendar maximizes program effectiveness. Documentation of surveillance activities, treatments, and disease events supports program evaluation and continuous improvement.

Record keeping for mange management supports both individual animal care and herd-level disease control efforts. Individual animal records should document any mange diagnoses, treatments administered, and treatment outcomes for future reference. Herd or flock records tracking disease incidence over time help identify risk factors and evaluate prevention program effectiveness. Treatment records including products used, dates, and withdrawal periods ensure food safety compliance and support marketing claims. Records of animal sources, quarantine procedures, and health certifications create audit trails for trace-back investigations and demonstrate due diligence in prevention.

Economic considerations heavily influence mange management decisions at both individual animal and herd levels. The costs of prevention programs including quarantine facilities, prophylactic treatments, and veterinary services must be balanced against potential losses from disease outbreaks. Treatment costs for clinical cases include medications, labor for treatment and follow-up, and potential withdrawal period impacts on marketing timing. Production losses from affected animals including reduced weight gain, lower milk yield, and hide or fleece damage represent significant economic impacts. Investment in prevention is generally more cost-effective than treating established outbreaks, making proactive management approaches economically advantageous for most operations.

All breeds and species of livestock are susceptible to mange, though clinical expression and infestation severity can vary based on various factors including genetics, production type, and management conditions. No breeds possess true genetic resistance to mange mites, though individual variation in clinical severity suggests some genetic influence on disease expression. Animals with compromised immune function from any cause, including genetic factors affecting immunity, may experience more severe clinical disease than immunocompetent herdmates. Breeds developed for specific production characteristics may be more or less tolerant of the metabolic stress imposed by mange infestation, affecting clinical outcomes without directly influencing susceptibility to mite infestation.

Production type and management intensity significantly influence mange risk and impact across different livestock categories. Intensive confinement operations with high animal density create ideal conditions for mite transmission and may experience more frequent and severe outbreaks than extensive grazing systems. Dairy cattle in tie-stall or freestall housing face higher transmission risk than range cattle with more space between individuals. Similarly, intensive pig production facilities may struggle with persistent sarcoptic mange problems despite treatment efforts. Sheep flocks managed for fine wool production may experience greater economic impact from psoroptic mange due to fleece damage, while meat-type sheep face impacts primarily through weight loss and reduced growth rates.

Genetic selection for mange resistance is not currently practiced in livestock breeding programs, though research has identified potential genetic markers associated with differential susceptibility in some species. Breeding decisions should focus on overall health and immune function rather than mange-specific resistance. Selection for animals that maintain good body condition and production under various stressors indirectly selects for disease resistance including resistance to the impacts of mange infestation. Maintaining genetic diversity within herds provides adaptive capacity to respond to various disease challenges. When purchasing breeding stock, focusing on animals from herds with good health management practices and low parasite burdens supports long-term herd health regardless of specific breed selection.

Several conditions commonly occur alongside mange or develop as complications of mite infestation. Lice infestations frequently co-occur with mange, as both parasites thrive under similar conditions of animal stress and close contact. Secondary bacterial infections of damaged skin are common complications, ranging from superficial pyoderma to deep abscesses and cellulitis in severe cases. Systemic illness including fever and depression may develop when secondary infections become severe. Nutritional deficiencies may predispose to mange or result from reduced feed intake during severe infestations, creating a cycle of declining health. Immunosuppressive conditions that predispose to mange may have other manifestations requiring investigation and treatment.

Numerous conditions cause clinical signs similar to mange and must be considered in differential diagnosis. Other ectoparasites including lice, keds, and various flies cause pruritus and skin damage that may resemble mange. Ringworm and other fungal skin infections cause alopecia and scaling with variable pruritus. Allergic skin conditions including insect bite hypersensitivity and contact dermatitis cause intense itching and skin inflammation. Photosensitization affects sun-exposed non-pigmented skin with a distinctive distribution pattern. Nutritional deficiencies particularly zinc and essential fatty acids cause skin abnormalities that may be confused with parasitic disease. Bacterial and viral skin infections can produce lesions requiring differentiation from mange.

Complications and long-term consequences of mange infestation extend beyond the acute parasitic disease. Permanent skin damage including scarring, texture changes, and abnormal hair growth may affect appearance and hide value even after successful treatment. Chronic skin changes may predispose to recurrent bacterial infections or other skin problems. Animals severely debilitated by mange may have long-term production impacts even after recovery. Economic losses from treatment costs, withdrawal periods, hide damage, and production losses can substantially impact farm profitability. Reportable forms of mange may trigger movement restrictions and regulatory requirements with additional economic and management implications.